|
Autoantibody Profiling for Serological Detection of Head and Neck Cancer
|
1R43CA139806-01
|
$217,801
|
$217,801
|
Khattar, Nada
|
20/20 GENESYSTEMS, INC.
|
|
Precisely Shaped Acoustic Ablation of Tumors Under 3D Ultrasound Image Guidance
|
4R44CA134169-02
|
$1,000,000
|
$1,000,000
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
PROSTATE, LUNG, COLO-RECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL EXPANSION F
|
N01CN075022-063
|
$1,617,215
|
$404,304
|
FOUAD, MONA
|
ALABAMA UNIV BIRMINGHAM:1109410
|
|
Experimental Models for Testing Novel Targets for Pancreatic Cancer Cell Invasion
|
5R21CA124931-02
|
$200,970
|
$200,970
|
MOUSA, SHAKER
|
ALBANY COLLEGE OF PHARMACY
|
|
Identification and Classification of Epigenetic Changes in Head and Neck Cancer
|
1R21CA131648-01A2
|
$219,120
|
$54,780
|
BELBIN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
DNA mismatch repair and cancer in murine models
|
5R01CA076329-12
|
$390,439
|
$390,439
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Pro & Anti-Inflammatory Cytokines in Colorectal Cancer
|
5R01CA122654-02
|
$625,384
|
$625,384
|
HO, GLORIA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
The transcriptional basis of tumor promotion
|
2R01CA104292-06A2
|
$374,795
|
$374,795
|
LOCKER, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
HEPADNAVIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA
|
5R01CA037232-25
|
$498,055
|
$498,055
|
Rogler, Charles
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Novel Methods for Molecular Analysis of Colorectal Cancer Tissue
|
2R44CA121473-02A2
|
$524,547
|
$524,547
|
Han, James
|
AMBERGEN, INC
|
|
A Novel Non-Invasive CRC Test Based on Mass Spec Of In Vitro Expressed Proteins
|
5R44CA119565-04
|
$469,320
|
$469,320
|
Han, James
|
AMBERGEN, INC
|
|
Improving colonoscopic miss rate by real time microvascular blood analysis
|
5R42CA130508-03
|
$346,336
|
$346,336
|
Roy, Hemant
|
AMERICAN BIOOPTICS, LLC
|
|
Radiation Therapy Oncology Group
|
2U10CA021661-33
|
$12,534,580
|
$125,346
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S1
|
$26,578
|
$2,924
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-22
|
$1,683,081
|
$185,139
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
5U24CA114734-05
|
$808,869
|
$161,774
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$2,446,507
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-11
|
$564,543
|
$112,909
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Storytelling to Promote Colorectal Screening in Primary Care Clinics
|
7R01CA116467-04
|
$409,128
|
$409,128
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Storytelling for Colorectal Health among Latinos
|
7R01CA118663-03
|
$520,985
|
$520,985
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
5R01CA090441-07
|
$381,250
|
$106,750
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
PHASE I AND II CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035158-010
|
$1,432,000
|
$143,200
|
CHOW, SHERRY
|
ARIZONA UNIV:1109859
|
|
Image-Guided System for Cancer Intervention
|
5R42CA115112-03
|
$158,937
|
$158,937
|
Vosburgh, Kirby
|
ASCENSION TECHNOLOGY CORPORATION
|
|
CellWell?: A microdevice for single cell analysis
|
5R21CA133551-03
|
$140,625
|
$140,625
|
NETTIKADAN, SAJU
|
ASPERA CORPORATION
|
|
Novel human anti-uPAR antibodies for the treatment of pancreatic cancer
|
1R43CA137884-01A1
|
$158,025
|
$158,025
|
FAN, XIAOMIN
|
AVANTGEN, INC.
|
|
Influence of Mint Flavorings and pH on Nicotine Absorption in Smokeless Tobacco
|
1R21CA141639-01
|
$182,736
|
$182,736
|
Pickworth, Wallace
|
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$72,968
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
PDX-1 is a Therapeutic Target for Pancreatic Cancer
|
5R01CA095731-07
|
$274,814
|
$274,814
|
BRUNICARDI, FRANCIS
|
BAYLOR COLLEGE OF MEDICINE
|
|
NSABP Participating Sites
|
5U10CA118735-04
|
$67,765
|
$10,165
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Obesity, H pylori and Risk of Barrett's Esophagus
|
5R01CA116845-03
|
$564,445
|
$564,445
|
El-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Surveillance for Hepatocellular Carcinoma among HCV-infected Veterans
|
5R01CA125487-03
|
$291,650
|
$291,650
|
El-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Roles of Zinc Transporter ZIP4 (SLC39A4) in Pancreatic Cancer Pathogenesis
|
1R21CA133604-01A2
|
$168,850
|
$168,850
|
LI, MIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Reducing Missed And Delayed Diagnoses In Cancer: Lessons From Aviation
|
5K23CA125585-03
|
$141,750
|
$46,778
|
SINGH, HARDEEP
|
BAYLOR COLLEGE OF MEDICINE
|
|
Hepatitis HBx-Mediated Pathogenesis
|
2R56CA095388-06A1
|
|
$0
|
SLAGLE, BETTY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Regulation of cell growth by RNA binding proteins
|
5R01CA100070-07
|
$266,844
|
$266,844
|
TIMCHENKO, NIKOLAI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Familial and Early Onset Colorectal Cancer
|
2R01CA072851-14
|
$342,796
|
$342,796
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
Pharmacological Impact of 3-Dimensional Extracellular Matrix on Tumor Cells
|
1R43CA141913-01
|
$198,120
|
$198,120
|
HAYES, STEVEN
|
BELLBROOK LABS, LLC
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$73,262
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$17,013
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-15
|
$99,433
|
$39,773
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Fibroblasts in Cancer
|
3R01CA125550-02S1
|
|
$0
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Fibroblasts in Cancer
|
3R01CA125550-02S2
|
$47,638
|
$23,819
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Fibroblasts in Cancer
|
5R01CA125550-02
|
$255,000
|
$127,500
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Optimizing localized therapy for primary liver cancer: a clinical trial and model
|
1K23CA139005-01A1
|
$169,020
|
$169,020
|
Miksad, Rebecca
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of Hemidesmosome Disassembly: Role of a6b4 integrin phosphorylation
|
5R01CA120202-03
|
$290,700
|
$29,070
|
RABINOVITZ, ISAAC
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
5K08CA129204-02
|
$135,270
|
$67,635
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of the Putative Tumor Suppressor PinX1 in the Etiology of Liver Cancer
|
5R01CA122434-04
|
$293,000
|
$293,000
|
ZHOU, XIAO Zhen
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Metabolic Syndrome as Pancreatic Cancer Etiology
|
5R21CA127794-02
|
$229,500
|
$229,500
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Geostatistical software for the analysis of individual-level epidemiologic data
|
2R44CA132347-02
|
$426,057
|
$144,859
|
GOOVAERTS, PIERRE
|
BIOMEDWARE
|
|
Case-only Cancer Clustering for Mobile Populations
|
2R44CA135818-02
|
$433,039
|
$433,039
|
Jacquez, Geoffrey
|
BIOMEDWARE
|
Total relevant funding to Digestive Diseases for this search: $450,822,745
|